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Abstract
Background: Organised stroke care saves lives and reduces disability. A clinical pathway might be
a form of organised stroke care, but the evidence for the effectiveness of this model of care is
limited.
Methods: This study was a retrospective audit study of consecutive stroke admissions in the
setting of an acute general medical unit in a district general hospital. The case-notes of patients
admitted with stroke for a 6-month period before and after introduction of the pathway, were
reviewed to determine data on length of stay, outcome, functional status, (Barthel Index, BI and
Modified Rankin Scale, MRS), Oxfordshire Community Stroke Project (OCSP) sub-type, use of
investigations, specific management issues and secondary prevention strategies. Logistic regression
was used to adjust for differences in case-mix.
Results: N = 77 (prior to the pathway) and 76 (following the pathway). The median (interquartile
range, IQR) age was 78 years (67.75–84.25), 88% were European NZ and 37% were male. The
median (IQR) BI at admission for the pre-pathway group was less than the post-pathway group: 6
(0–13.5) vs. 10 (4–15.5), p = 0.018 but other baseline variables were statistically similar. There were
no significant differences between any of the outcome or process of care variables, except that
echocardiograms were done less frequently after the pathway was introduced. A good outcome
(MRS<4) was obtained in 66.2% prior to the pathway and 67.1% after the pathway. In-hospital
mortality was 20.8% and 23.1%. However, using logistic regression to adjust for the differences in
admission BI, it appeared that admission after the pathway was introduced had a significant negative
effect on the probability of good outcome (OR 0.29, 95%CI 0.09-0.99).
Conclusion: A clinical pathway for acute stroke management appeared to have no benefit for the
outcome or processes of care and may even have been associated with worse outcomes. These
data support the conclusions of a recent Cochrane review.
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A number of randomised controlled trials and systematic
reviews show that organised stroke care, mainly in the
form of a stroke unit, reduces early mortality and
improves disability for patients with stroke [1]. The imple-
mentation of this research into clinical practice has been
slow. Only recently have most United Kingdom hospitals
established stroke units, although only a minority of
stroke patients appear to access them [2]. In New Zealand,
very few hospitals have developed organised stroke care
[3]. One of the barriers to developing a dedicated stroke
unit may be the re-distribution of resources away from
acute medical services or the investment of new resources.
An alternative way of delivering organised stroke care may
be a clinical pathway. This require fewer resources, being
mainly a tool for encouraging clinicians to implement evi-
dence-based management decisions at key stages during a
patient's hospitalisation. The assumption is that the com-
ponents of a stroke unit could be mimicked by general
medical care if information about these components were
explicit and available at the salient point of patient care.
Clinical pathways have been promoted in a number of
medical conditions such as acute coronary syndromes [4],
exacerbations of chronic obstructive airways disease [5],
and peptic ulcer disease [6]. The evidence for the effective-
ness of clinical pathways in stroke is mainly limited to
non-randomised studies and is consequently not strong.
A systematic review of 3 randomised and 7 non-ran-
domised studies concluded that there is no evidence that
clinical pathways improve mortality or dependency for
patients with stroke [7]. Despite the poor evidence base,
clinical pathways are still recommended as a means of
promoting best practice in hospital care for people with
stroke [8].
In April 2003, a clinical pathway was introduced in Hutt
Hospital to promote best practice for patients with acute
stroke admitted to the general medical service. Given the
limited evidence for clinical pathways in stroke care, it was
felt important to audit the outcomes and processes of care
shortly after implementation of the pathway. The princi-
pal aim of this audit was to assess whether the outcomes
at discharge were improved for patients with stroke, after
the pathway was introduced compared to a cohort man-
aged in hospital prior to the pathway. We also assessed
whether there were changes in the use of investigations,
management of specific problems in acute stroke and the
use of secondary prevention treatment at discharge from
hospital.
Methods
The design of this audit was a retrospective case-note
review of two groups of consecutive patients with stroke
admitted to a district general hospital serving an urban
population of 135,000 people. About 150 patients with
stroke are admitted annually to the general medical serv-
ice. Neurology and neuro-surgical services are provided at
a regional centre about 25 minutes drive from Hutt Hos-
pital. Inpatient rehabilitation is provided within an age-
unrelated rehabilitation service on the hospital campus.
The stroke pathway consisted of a paper document
inserted into each stroke admission, either in the emer-
gency department or medical unit. It contained general
advice about acute stroke management and then detailed
daily activities for each of the first 5 days of the acute
admission. The daily activities were listed under medical,
nursing, therapist and discharge planning headings. Each
item was to be ticked, initialled and dated as achieved by
relevant staff on a daily basis. The content of the pathway
was determined by literature review, consensus state-
ments and regular meetings of a stroke pathway team over
a 3-year period.
Cases were identified from International Codes for Diag-
nosis (ICD-10) discharge codes for the 6-month periods
of June through December 2003 (pre-pathway group) and
June through December 2004 (post-pathway group). In
addition, after the pathway was introduced a logbook was
kept that prospectively recorded patients with stroke
admitted to the medical unit; additional cases were iden-
tified from this source. The case-notes were reviewed to
confirm that the primary reason for admission was stroke
according to the World Health Organisation definition
[9].
The following data were abstracted from the case-notes of
confirmed stroke patients: length of stay on medical and
rehabilitation services, demographics, neurological
impairments necessary to classify the stroke according to
the Oxfordshire Community Stroke Project (OCSP) [10],
Charlson Comorbidity Index [11], Barthel Index [12] at
admission and discharge, estimated Modified Rankin
Scale [13] prior to admission and at discharge, discharge
disposition, presence and management of specific issues
(fever, hyperglycemia, hypertension, prophylaxis for
thromboembolism, aspirin given within 48 hours of
admission), use of investigations (computed tomogra-
phy, magnetic resonance imaging, echocardiography,
carotid doppler ultrasound, fasting lipid profile, acute
phase marker [erythrocyte sedimentation rate or C-reac-
tive protein]), and use of secondary prevention treatment
at discharge (blood pressure lowering treatment, smoking
cessation programme, optimisation of diabetic control,
cholesterol lowering treatment, anti-platelet treatment,
anticoagulation for atrial fibrillation).
The Barthel Index (BI) is a 10-item scale of independence
in mobility and self-care activities, with scores rangingPage 2 of 7
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pendence). Scores of 0 to 10 typically indicate severe func-
tional disability. Although the BI was not routinely
administered at admission and discharge during either
period, it was possible to retrospectively score the items by
reference to nursing, occupational therapy and physio-
therapy notes within the case-record. The Modified
Rankin Scale (MRS) is a simple 6-level categorisation of
functional independence: 0 indicates no symptoms, 1
indicates symptoms but no disability, 2 indicates slight
disability but independent, 3 indicates moderate disabil-
ity but can walk independently, 4 indicates moderately
severe disability, 5 indicates severe disability. In-hospital
functional status at admission was measured with the BI
rather than the MRS since the BI is more informative and
the MRS is more frequently employed as a community-
based outcome, rather than an adequately scaled func-
tional index for hospital inpatients [14].
A good outcome at discharge from hospital was defined in
two ways: discharge to home, nearly independent survival
(MRS<4) and independent survival (MRS<3). A MRS<4
has not previously been used to define a good outcome in
acute stroke trials, but was chosen here to capture modest
improvements in patients severely affected by stroke. Non-parametric statistical tests were used to evaluate dif-
ferences between the two cohorts (Mann-Whitney U for
continuous or ordinal data, Chi-square for categorical
Case identification flow-chartFigure 1
Case identification flow-chart.
Table 1: Baseline characteristics
Pre-path Post-path p-value
Age (median, IQR) 78(70–86) 77(65–83) NS
Gender (Male N, %) 34(44.2) 33(43.4) NS
Ethnicity (European N, %) 64(83.1) 69(90.8) NS
Barthel Index admission (median, IQR) 6(0–13.5) 9.5(4–15) 0.025





Outcomes at hospital dischargeFigure 2
Outcomes at hospital discharge. Top: Discharge location 
from medical unit. Centre: Discharge location from hospital. 
Bottom: Modified Rankin Scale of survivors at discharge from 
hospital.Page 3 of 7
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ence of being admitted in the post-pathway group upon
outcome was assessed using logistic regression models
incorporating age, gender, comorbidity index, admission
BI, whether transferred to rehabilitation and OCSP classi-
fication. SPSS version11.5 was used for all analyses.
Results
In the pre-pathway period, 136 patients had discharge
codes that indicated stroke. The case-records of 91% of
these were examined and 77 (62%) were confirmed to
have a primary admission reason of stroke (Figure 1). In
the post-pathway period, 119 patients had discharge
codes that indicated stroke and an additional 17 patients
were identified from the stroke logbook. Of these, 82% of
the case-records were examined and 76 (68%) were con-
firmed to have a primary admission of stroke. There was
documented evidence that the stroke pathway was used in
61% of these patients.
The two cohorts were similar in terms of age, OCSP classi-
fication, gender and ethnicity but the pre-pathway group
had worse functional status at admission (Table 1).
Length of stay (LOS) on medical or rehabilitation units
was not different between the two cohorts (Table 2).
Although there was a trend to shorter total hospital LOS
(a difference in median LOS of 5.5 days following the
introduction of the pathway due to fewer patients being
transferred to rehabilitation) (Figure 2), this apparent dif-
ference was not statistically significant.
Discharge disposition from hospital was very similar in
the two cohorts but there was a trend towards fewer
patients transferred to inpatient rehabilitation following
introduction of the pathway and more patients discharged
directly home from the acute medical unit (Figure 2). Sim-
ilarly there were no differences in the proportion of survi-
vors at discharge classified by MRS.
Since there were differences in admission BI between the
two cohorts, we adjusted for this using logistic regression.
Using logistic regression to model the logit probability of
a good outcome (defined as MRS<4 at discharge) with
age, admission BI, transfer to inpatient rehabilitation,
admission during the pathway period, comorbidity score,
and OCSP subtype as independent variables, we found
that admission during the pathway period had an inde-
pendent adverse effect on outcome (Table 3). This effect
remained if the definition of a good outcome was MRS<3
(model not shown), but the independent effect of transfer
to rehabilitation was not significant in this second model.
A similar analysis was performed excluding patients for
whom there was no evidence of pathway use in the post-
pathway period, and very similar findings were obtained
(data not shown).
Table 4 lists the use of investigations, management of spe-
cific issues and secondary risk factor management. There
were significantly fewer echocardiograms performed dur-
ing the hospital stay after the pathway was introduced but
no other significant differences in the use of investigations
were observed. Fewer than half of patients had fasting lip-
ids and glucose measured during the hospital stay, which
is unsatisfactory. There were no significant differences in
the early use of aspirin, paracetamol for fever, treatment of
acute hyperglycemia, acute blood pressure management
or the use of DVT prophylaxis. Neither were there differ-
ences in the proportions of patients having appropriate
secondary prevention treatment at discharge. Under-treat-
ment with warfarin for atrial fibrillation seems likely in
both cohorts.
Discussion
This observational retrospective audit does not provide
evidence to support the use of a clinical pathway in an
acute setting for stroke patients, when the objective of
such a pathway is to improve discharge outcomes. There
are other possible advantages to clinical pathways such as
improved documentation, compliance with funding
requirements and ease of audit, but this study did not
address these issues. Clearly, the non-randomised design
and retrospective design does not permit straightforward
interpretation of the finding that admission in the post-
pathway period was associated with an adverse outcome.
It may be that other un-measured variables could account
for this finding, such as changes in staffing levels, provi-
sion of residential care or differences in informal supports
available to patients.
One limitation to the retrospective design is the likeli-
hood that not all stroke admissions were identified. The
inaccuracy of discharge coding is well known. However, it
is likely that such a bias was present to the same extent in
Table 2: Length of stay (LOS), median (IQR)
Pre-path Post-path p-value
Medical ward (days) 6(3–9) 5.5(3–9) NS
Rehabilitation ward (days) 21(13.25–30.75 21(15–31) NS
Total hospital LOS 16(4–30) 10.5(4–26.5) NSPage 4 of 7
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accounted for a similar proportion of cases identified
from discharge codes in each group.
Similarly, retrospective determination of the admission
Barthel Index from case-notes is unlikely to be strictly
accurate. However, the same method of determining BI
was used for both pre- and post-pathway groups, so a sys-
tematic bias is unlikely. Also, the calculation of the Bar-
thel Index was not blinded to whether the sample was
before or after the introduction of the pathway. We can-
not exclude the possibility that this could have affected
the scores and could conceivably led to the observed dif-
ference in mean Barthel Index scores at admission. How-
ever, we feel that this is unlikely since the trends in other
data also suggested that strokes admitted after introduc-
tion of the pathway were milder – shorter total hospital
length of stay and fewer strokes transferred to rehabilita-
tion.
It is also possible that admission practices changed after
the introduction of the pathway. Although there was no
Table 4: Medical management of stroke patient during hospital stay
Before the introduction of 
pathway
After the introduction of 
pathway
p-value
Investigations during the 
admission
CT scan in 1st 48 hrs 96% 92% 0.293
Carotid duplex ultrasound 26% 28% 0.817
Echocardiogram 42% 26% 0.047
ESR or CRP in 1st 48 hrs 57% 61% 0.143
Fasting blood sugar and lipids 32% 44% 0.143
MRI 10% 5% 0.238
Specific medical issues Aspirin given in first 48 hours to patients 
without contraindications
26/55 (46%) 40/66 (61%) 0.117
Paracetamol given to those with fever > 38°C in 
first 48 hours
3/4 (75%) 5/5 (100%) 0.574
Acute blood pressure management consistent 
with guideline
63.6% 71.1% 0.328
Prophylaxis for deep vein thrombosis (except 
aspirin)
20.8% 14.5% 0.306
Hypoglycemic agents given to those with blood 
sugar >15 mmol/l in first 48 hours
1/2 (50%) 2/2 (100%) 0.312
Risk factor treatment at 
discharge
Anti-hypertensive treatment if sBP>140 or 
dBP>90 at any time during admission
44/50 (88%) 51/58 (88%) 0.242
Warfarin if ECG shows atrial fibrillation 6/18 (33%) 4/10 (40%) 0.264
Statin if total cholesterol > 3.5 42/55 (76%) 48/61 (79%) 0.341
Cessation programme for current smokers 5/10 (50%) 8/10 (80%) 0.638
Optimisation of glycemic control if diabetes 
present
8/12 (67%) 8/9 (100%) 0.410
US carotid arteries requested or performed if 
anterior circulation infarct
19/60 (32%) 24/59 (41%) 0.610
Table 3: Logistic regression model for discharge MRS<4 (-2log likelihood 94.9, R2 0.48, p < 0.001)
B(SE) OR(95%CI) p-value
Comorbidity index -0.28(0.24) 0.76(0.47–1.22) 0.25
Age 0.01(0.02) 1.01(0.96–1.06) 0.81
Admission BI 0.39(0.07) 1.48(1.29–1.70) <0.001
OCSP class TACS 1.00 (ref)
PACS -0.11(0.88) 0.90(0.16–5.06) 0.90
POCS 2.10(1.44) 8.16(0.48–138) 0.15
LACS -0.90(1.16) 0.41(0.04–3.90) 0.43
Post-pathway period -1.23(0.63) 0.29(0.09–0.99) 0.05
Female gender 0.57(0.59) 1.78(0.56–5.63) 0.33
Transfer to Rehab. 1.27(0.56) 3.55(1.19–10.63) 0.02Page 5 of 7
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ment for stroke probably meant that increased numbers
of less severe strokes were admitted after the introduction
of the pathway; this is strongly suggested by the better
admission functional status and the increased proportion
of patients discharged directly home from the acute med-
ical unit. This difference in case-mix does confound the
interpretation of outcomes between the two cohorts, but
statistical adjustment suggests a worse outcome for
strokes admitted after the pathway was introduced.
A Cochrane systematic review of in-hospital care path-
ways for stroke showed that evidence from mainly non-
randomised studies suggests that stroke pathways may
reduce urinary tract infection and re-admission rates and
increase rates of having a CT brain study or carotid duplex
study [7]. However, there was no evidence that in-hospital
pathways reduced length of stay or improved outcome at
discharge (death, dependency or destination). Further-
more, evidence from randomised trials suggested that
quality of life and patient satisfaction were worse in
patients on a stroke pathway.
If it is true that stroke pathways fail to improve outcome
at discharge and may even be associated with an adverse
effect upon outcome, it is interesting to speculate why this
might be so. It may be that the complexity of acute stroke
care cannot be adequately described within a clinical
pathway and that simple guidelines cannot hope to
replace experienced, knowledgeable staff who can think
flexibly. It may be that pathways channel clinical staff into
routines that may not be best practice for individual
patients.
We have previously demonstrated an ambiguous relation-
ship between process of care and outcomes for stroke
patients [16]. However, it has been suggested that rela-
tively simple measures might be able to reduce unneces-
sary catheter use and prevent aspiration [17] without
implementing a full clinical pathway. Certainly, a clinical
pathway is not without some opportunity cost: multidis-
ciplinary staff time in meetings, researching the literature
and writing the pathway, staff training (which needs to be
regularly updated), and in promoting compliance with
the pathway.
Conclusion
It seems likely that the as-yet-unidentified components of
stroke care within comprehensive stroke units that
account for the effectiveness of such units, are not con-
tained within the clinical pathway approach. This audit
strengthens the argument for stroke unit care to be the




MRS Modified Rankin Scale
ICD-10 International Classification of Disease, 10th edi-
tion
OCSP Oxfordshire Community Stroke Project
SPSS Statistics Package for the Social Sciences
LOS Length of stay
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